Summary
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.
History
SK Biotekhno Co. was established in 1991 as the first biopharmaceutical company in South Korea. It was founded as part of a national effort to promote the biotechnology industry and to provide high-quality biopharmaceutical products to the public. Since then, it has become the world's leading innovator of biotech drugs and a leader in the sector
Mission
SK Biotekhno’s mission is to develop research on life sciences, create innovative biopharmaceuticals, and create a better life for all
Vision
SK Biotekhno’s vision is to be the best biopharmaceutical company in the world, creating innovative therapies and improving healthcare outcomes.
Key Team
Dr. Jin-yong Park (Head of Quality Unit)
Dr. Harry Kleanthous (Exec. VP of Vaccine R&D Strategy & External Innovation)
Dr. Sally Choe (Head of Global Clinical Devel. & Regulatory Affairs)
Recognition and Awards
SK Biotekhno has won numerous awards in recognition of its innovative drugs and cutting-edge research, including the Presidential Award, the Dong-A Pharmaceutical Award and the SK Foundation Award
References
